8-K current report · filed Nov 4, 2026

Outset Medical, Inc. (OM) 8-K Current Report: November 4, 2026

Item 2.02Item EX-99.1OM overview

Short answer

Outset Medical, Inc. (OM) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 earnings announcement for quarter ended September 30, 2026.

Outset Medical, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 earnings announcement for quarter ended September 30, 2026
  • Press release furnished as Exhibit 99.1, containing financial results and management commentary
  • Earnings conference call scheduled for November 4, 2026

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $33.6M, up 14% YoY and 6% sequentially, supporting continued commercial momentum
  • Console revenue $10.5M, up 26% YoY, while recurring revenue reached $23.1M, up 10%
  • Gross margin expanded to 40.7% from 39.4%, led by service margin improving to 32.4% from 24.8%
  • GAAP net loss narrowed to $14.7M from $17.8M, but non-GAAP net loss widened to $12.9M from $12.4M
  • Cash, investments and restricted cash totaled $140.7M after $10.3M quarterly cash use; 2026 revenue guidance reaffirmed at $125M-$130M

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Outset Medical, Inc. 8-K filings

Get the next OM 8-K as it lands

Follow OM for push alerts, or ask the research agent what this filing means.